Clinical Trial Update: Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial sponsored by the National Cancer Institute evaluating aspirin for colorectal cancer prevention in high-risk individuals has completed, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Colorectal Precancerous Lesion
• Rectal Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colon Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED | Results posted: 2017-05-31